Loading…
Jeena Sikho Lifecare (JSLL)₹332.55+0.74%Wellness
In the Jun 2026 quarter (consolidated), Jeena Sikho Lifecare reported sales of ₹224 Cr, up 28.7% from Jun 2025, and net profit of ₹65.77 Cr, up 29.4% year on year. For the year to Mar 2026, sales were ₹802 Cr and net profit ₹221 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales | 114 | 116 | 139 | 174 | 190 | 222 | 216 | 224 |
| Expenses | 74.10 | 86.15 | 93.06 | 96.18 | 98.16 | 121 | 138 | 132 |
| Operating Profit | 39.95 | 29.99 | 45.94 | 78.87 | 91.97 | 101 | 77.91 | 91.97 |
| OPM % | 35.0% | 26.0% | 33.0% | 45.0% | 48.0% | 45.0% | 35.9% | 41.0% |
| Other Income | 3.01 | 0.00 | 0.00 | 1.01 | 1.01 | 3.01 | 3.01 | 14.04 |
| Interest | 2.01 | 4.01 | 3.01 | 2.01 | 4.01 | 3.01 | 4.01 | 3.01 |
| Depreciation | 6.02 | 8.03 | 9.04 | 10.04 | 10.04 | 11.04 | 16.05 | 15.06 |
| Profit before tax | 35.05 | 18.04 | 34.04 | 69.14 | 79.21 | 89.14 | 61.14 | 88.18 |
| Tax % | 24.9% | 25.9% | 24.9% | 24.9% | 24.9% | 24.9% | 25.9% | 24.9% |
| Net Profit | 26.92 | 12.94 | 24.90 | 50.82 | 58.78 | 66.73 | 44.85 | 65.77 |
| EPS (Rs) | 2.15 | 1.07 | 2.05 | 4.14 | 4.75 | 5.38 | 3.64 | 5.33 |
| Mar 2022 | Mar 2023 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|
| Sales | 147 | 205 | 469 | 802 | 853 |
| Expenses | 128 | 159 | 328 | 452 | 490 |
| Operating Profit | 17.99 | 45.94 | 141 | 349 | 363 |
| OPM % | 12.0% | 21.9% | 30.0% | 43.9% | 42.5% |
| Other Income | 1.01 | 3.01 | 7.02 | 8.02 | 21.07 |
| Interest | 1.01 | 1.01 | 11.01 | 13.02 | 14.04 |
| Depreciation | 3.01 | 3.01 | 29.12 | 48.16 | 52.19 |
| Profit before tax | 15.02 | 44.10 | 108 | 298 | 318 |
| Tax % | 25.9% | 24.0% | 25.9% | 24.9% | — |
| Exceptional items | 0.99 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | 10.95 | 33.89 | 79.68 | 221 | 236 |
| EPS (Rs) | 1.24 | 2.73 | 6.45 | 17.91 | 19.10 |
| Dividend payout % | 0.0% | 8.0% | 0.0% | 25.0% | — |
| Mar 2022 | Mar 2023 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Equity Capital | 9.99 | 13.98 | 24.99 | 24.99 |
| Reserves | 25.96 | 112 | 231 | 442 |
| Borrowings | 6.99 | 0.99 | 117 | 127 |
| Other Liabilities | 18.08 | 24.11 | 46.22 | 80.38 |
| Total Liabilities | 62.02 | 151 | 419 | 674 |
| Fixed Assets | 29.04 | 60.08 | 255 | 294 |
| CWIP | 4.99 | 0.99 | 10.98 | 1.99 |
| Investments | 0.00 | 5.01 | 4.01 | 110 |
| Other Assets | 27.99 | 85.89 | 149 | 269 |
| Inventories | 6.01 | 4.01 | 12.01 | 20.03 |
| Trade receivables | 8.99 | 21.97 | 84.92 | 69.99 |
| Cash & equivalents | 2.99 | 31.96 | 22.97 | 109 |
| Total Assets | 62.02 | 151 | 419 | 674 |
| Mar 2022 | Mar 2023 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Cash from operating activity | 15.96 | 14.97 | 83.81 | 254 |
| Cash from investing activity | −18.04 | −33.03 | −64.13 | −202 |
| Cash from financing activity | −4.99 | 47.95 | −21.98 | −58.98 |
| Net cash flow | −7.01 | 29.02 | −2.01 | −7.01 |
| Capex | 21.97 | 36.98 | 41.95 | 33.98 |
| Free cash flow | −1.99 | −14.98 | 44.88 | 221 |
| CFO / OP % | 112.0% | 50.0% | 84.0% | 94.0% |
| Mar 2022 | Mar 2023 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Debtor days | 24 | 40 | 67 | 33 |
| Inventory days | 149 | 85 | 78 | 81 |
| Days payable | 110 | 127 | 107 | 93 |
| Cash conversion cycle | 63 | 0 | 39 | 21 |
| Working capital days | −13 | 27 | 29 | 57 |
| ROCE % | — | 52.0% | — | 64.0% |
For the Jun 2026 quarter, Jeena Sikho Lifecare reported sales of ₹224 Cr, up 28.7% year on year and net profit of ₹65.77 Cr, up 29.4% year on year. The operating margin was 41.0%.
Jeena Sikho Lifecare's sales for the year to Mar 2026 were ₹802 Cr; over the last twelve months they were ₹853 Cr.
Net profit for the year to Mar 2026 was ₹221 Cr, and ₹236 Cr over the last twelve months. Earnings per share over the same trailing period were ₹19.10.
Jeena Sikho Lifecare reported borrowings of ₹127 Cr at Mar 2026, against cash and equivalents of ₹109 Cr.
Cash from operations was ₹254 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹221 Cr.